Surgical management of the fourth ventricular tumors using telovelar approach

pay.thelady61 shared this article with you from Inoreader Surgical management of the fourth ventricular tumors using telovelar approach and the role of neuroendoscopy: Post-operative outcome and long-term results in a series of 52 cases Via Clinical Neurology and Neurosurgery Publication date: Available online 8 December 2020 Source: Clinical Neurology and Neurosurgery Author(s): Ehsan Nazari Maloumeh, Reza Jalili Khoshnoud, Kaveh Ebrahimzadeh, Hesameddin Hoseini Tavassol, Sepideh Salari, Ali Mousavinejad, Atiye Kargari, Mohammad Samadian, Omidvar Rezaei View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.

FAM46A expression is elevated in glioblastoma and predicts poor prognosis of patients

pay.thelady61 shared this article with you from Inoreader FAM46A expression is elevated in glioblastoma and predicts poor prognosis of patients Via Clinical Neurology and Neurosurgery Publication date: Available online 8 December 2020 Source: Clinical Neurology and Neurosurgery Author(s): Yibiao Wang, Renduan Cai, Pengcheng Wang, Chuixue Huang, Chaocai Zhang, Zhaohui Liu View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.

Delayed transhemispheric propagation of electrographic seizures following functional hemispherectomy

pay.thelady61 shared this article with you from Inoreader Delayed transhemispheric propagation of electrographic seizures following functional hemispherectomy Via Clinical Neurology and Neurosurgery Publication date: Available online 8 December 2020 Source: Clinical Neurology and Neurosurgery Author(s): Oliver Phillips, Petya Radoeva, Luca Bartolini View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.

Early-Onset Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay Diagnosed in Adulthood

pay.thelady61 shared this article with you from Inoreader Two Cases of Early-Onset Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay Diagnosed in Adulthood Via Clinical Neurology and Neurosurgery Publication date: Available online 8 December 2020 Source: Clinical Neurology and Neurosurgery Author(s): Turgut Sahin, Fatma Tugra Karaarslan, Rezzak Yilmaz, Şeyma Tekgül, Ayşe Nazlı Başak, Muhittin Cenk Akbostanci View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.

Papillary Tumor of the Pineal Region in Pediatric Populations: An Additional Case and Systematic Review of a Rare Tumor Entity

pay.thelady61 shared this article with you from Inoreader Papillary Tumor of the Pineal Region in Pediatric Populations: An Additional Case and Systematic Review of a Rare Tumor Entity Via Clinical Neurology and Neurosurgery Publication date: Available online 8 December 2020 Source: Clinical Neurology and Neurosurgery Author(s): Mansour Mathkour, Joshua Hanna, Naser Ibrahim, Tyler Scullen, Mitchell D. Kilgore, Cassidy Werner, Ian Cormier, Pierce Spencer, Joseph R. Keen, Cuong J. Bui View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.

Reconstruction of chronic scalp erosion after deep brain stimulation surgery

pay.thelady61 shared this article with you from Inoreader Reconstruction of chronic scalp erosion after deep brain stimulation surgery Via Plastic, Reconstructive & Aesthetic Surgery To investigate the reconstructive effectiveness for chronic scalp erosion after deep brain stimulation (DBS). View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.

A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder

pay.thelady61 shared this article with you from Inoreader A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder Via ClinicalTrials.gov: HEAD AND NECK | Open Studies | updated in the last 14 days Condition:   Urinary Bladder Neoplasms Interventions:   Drug: Cetrelimab;   Drug: TAR-200;   Drug: Cisplatin;   Drug: Gemcitabine;   Radiation: Conventional radiation therapy;   Radiation: Hypo-fractioned radiation therapy Sponsor:   Janssen Research & Development, LLC Not yet recruiting View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.

Triamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSF

pay.thelady61 shared this article with you from Inoreader Triamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSF Via ClinicalTrials.gov: HEAD AND NECK | Open Studies | updated in the last 14 days Condition:   Vestibular Schwannoma Intervention:   Drug: Triamcinolone Acetonide 40mg/mL Sponsor:   Medical University of Vienna Recruiting View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.

The Effect of Non-resistance Technique for Neck Pain Due to a Whiplash Injury

pay.thelady61 shared this article with you from Inoreader The Effect of Non-resistance Technique for Neck Pain Due to a Whiplash Injury Via ClinicalTrials.gov: HEAD AND NECK | Open Studies | updated in the last 14 days Condition:   Whiplash Injury of Cervical Spine Interventions:   Other: non-resistance therapy;   Other: acupuncture;   Other: chuna;   Other: pharmacoacupuncture;   Drug: Korean herbal medicine Sponsor:   Jaseng Medical Foundation Recruiting View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.

Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer

pay.thelady61 shared this article with you from Inoreader Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer Via ClinicalTrials.gov: HEAD AND NECK | Open Studies | updated in the last 14 days Conditions:   Clinical Stage III Gastric Cancer AJCC v8;   Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8;   Clinical Stage IV Gastric Cancer AJCC v8;   Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8;   Clinical Stage IVA Gastric Cancer AJCC v8;   Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Clinical Stage IVB Gastric Cancer AJCC v8;   Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8;   Locally Advanced Unresectable Gastric Adenocarcinoma;   Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma;   Metastatic  Gastric Adenocarcinoma;   Metastatic Gastroesophageal Junction Adenocarcinoma;   Pathologic Stage III Gastric Cancer AJCC v8;   Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage IIIA Gastric Cancer AJCC v8;   Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage IIIB Gastric Cancer AJCC v8;   Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage IIIC Gastric Cancer AJCC v8;   Pathologic Stage IV Gastric Cancer AJCC v8;   Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8;   Postneoadjuvan t Therapy Stage III Gastric Cancer AJCC v8;   Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8;   Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 Interventions:   Drug: Paclitaxel;   Other: Quality-of-Life Assessment;   Biological: Ramucirumab;   Drug: Trifluridine and Tipiracil Hydrochloride Sponsors:   Academic and Community Cancer Research United;   National Can cer Institute (NCI) Not yet recruiting View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.

Study of Pharmacokinetic, Safety, Immunogenicity and Efficacy of CMAB819 and Nivolumab in R/M HNSCC

pay.thelady61 shared this article with you from Inoreader Study of Pharmacokinetic, Safety, Immunogenicity and Efficacy of CMAB819 and Nivolumab in R/M HNSCC Via ClinicalTrials.gov: HEAD AND NECK | Open Studies | updated in the last 14 days Condition:   Squamous Cell Carcinoma of the Head and Neck Interventions:   Drug: CMAB819;   Drug: Nivolumab Sponsor:   Taizhou Mabtech Pharmaceutical Co.,Ltd Recruiting View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.

Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics

pay.thelady61 shared this article with you from Inoreader Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics Via Frontiers in Oncology | New and Recent Articles Recent studies have provided several insights into acute myeloid leukemia. Studies based on molecular biology have identified eight functional mutations involved in leukemogenesis, including driver and passenger mutations. Insight into Leukemia stem cells (LSCs) and assessment of cell surface markers have enabled characterization of LSCs from hematopoietic stem and progenitor cells. Clonal evolution has been described as having an effect similar to that of microenvironment alterations. Such biological findin gs have enabled the development of new targeted drugs, including drug inhibitors and monoclonal antibodies with blockage functions. Some recently approved targeted drugs have resulted in new therapeutic strategies that enhance standard intensive chemotherapy regimens as well as supportive care regimens. Besides the progress made in adoptive immunotherapy, since allogenic hematopoietic stem cell transplantation enabled the development of new T-cell transfer therapies, such as chimeric antigen receptor T-cell and transgenic TCR T-cell engineering, new promising strategies that are investigated. View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.

MR-Guided Radiotherapy for Prostate Cancer

pay.thelady61 shared this article with you from Inoreader MR-Guided Radiotherapy for Prostate Cancer Via Frontiers in Oncology | New and Recent Articles External beam radiotherapy remains the primary treatment modality for localized prostate cancer. The radiobiology of prostate carcinoma lends itself to hypofractionation, with recent studies showing good outcomes with shorter treatment schedules. However, the ability to accurately deliver hypofractionated treatment is limited by current image-guided techniques. Magnetic resonance imaging is the main diagnostic tool for localized prostate cancer and its use in the therapeutic setting offers anatomical informat ion to improve organ delineation. MR-guided radiotherapy, with daily re-planning, has shown early promise in the accurate delivery of radiotherapy. In this article, we discuss the shortcomings of current image-guidance strategies and the potential benefits and limitations of MR-guided treatment for prostate cancer. We also recount present experiences of MR-linac workflow and the opportunities afforded by this technology. View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.